IPO

Standard Glass Lining IPO review- valued at ₹410 crore, shows strong fundamentals with 10% revenue and 12% PAT growth. High GMP (~60%) suggests strong demand…

Davin sons IPO review – company reported a 242% increase in revenue and a 190% rise in profit after tax (PAT) between the financial years ending March 31, 2023, and March 31, 2024, the financials appear somewhat suspicious…

Leo Dry Fruits and Spices IPO apply or not? – If the GMP is above 40-50% on 3rd day of IPO opening, investors can consider applying for listing gains. However, if the GMP is lower, it would be prudent to apply only for long-term investment

Technichem Organics IPO Apply or not – The IPO is an SME offering, which inherently carries potential for significant listing gains. the Grey Market Premium (GMP) is already at 20% before opening the IPO

Citichem India IPO Review – The IPO is an SME offering, which inherently carries potential for significant listing gains. the Grey Market Premium (GMP) is already at 42% on first day, reflecting strong investor interest and positive anticipation.

The IPO is an SME offering, which inherently carries potential for significant listing gains, often in the range of 2X to 3X. Despite not being open yet, the Grey Market Premium (GMP) is already at 21%, reflecting strong investor interest and positive anticipation.

Indo Farm Equipment Limited, started in 1994, makes tractors, pick-and-carry cranes, and other harvesting equipment. Indo Farm Equipment Limited book-built issue valued at ₹260.15 crores. The offering consists of a fresh issue of 0.86 crore shares, raising ₹184.90 crores, aimed at funding the company’s growth and operational requirements. Additionally, there is an offer for…

The Grey Market Premium (GMP) stands at an impressive 61% of Unimech Aerospace, indicating strong demand and expectations for good listing gains. Fundamentally, the company appears solid—it is a small-sized, profitable business. Investors should apply for the IPO for good listing gain and for long term as well.

Carraro India Ltd’s IPO has seen a lackluster response, with low subscription rates across categories and a grey market premium (GMP) of 0%, indicating no immediate listing gains. While retail investors seeking short-term profits may avoid this IPO, the company’s strong fundamentals make it a compelling choice for long-term investors looking for sustained growth.

Discover the latest GMP of Senores Pharmaceuticals Limited IPO, which boasts a grey market premium (GMP) of 40.92%. This IPO features a book-built issue of ₹582.11 crores, including a fresh issue of ₹500 crores and an offer for sale of ₹82.11 crores.